Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Medical professionals, medical students, ACTUP New York, and their supporters held a rousing protest rally outside Pfizer World Headquarters in New York. At the beginning of 2019, the corporate giant announced price increases for 40 of its drugs. (Photo: Erik McGregor/Pacific Press/LightRocket via Getty Images)

Medical professionals, students, ACTUP New York, and their supporters protested outside Pfizer's global headquarters in New York City on March 2, 2019. (Photo: Erik McGregor/Pacific Press/LightRocket via Getty Images)

Amid Corporate Dems' Threats, New Poll Shows 83% of Voters Back Drug Pricing Reform

"The Democrats must stand with the people," said Sen. Bernie Sanders, "not fold."

Julia Conley

Further poking holes in reports that the lawmakers currently standing in the way of passing President Joe Biden's agenda are "moderates," new polling out Tuesday showed that large majorities of voters want the federal government to be empowered to negotiate for lower drug prices—a proposal long championed by Democrats which has now become a sticking point in the Build Back Better Act.

"Even with PhRMA spending millions on scare tactics and lies—voters know the truth."

According to the Kaiser Family Foundation (KFF) survey taken between September 23 and October 4, 83% of respondents said the government should be able to secure lower drug prices for patients who use both Medicare plans and private health insurance plans.
"We didn't poll on baseball, motherhood, and apple pie, but I'm not sure they would score much higher," tweeted Larry Levitt, executive vice president for health policy at KFF.
The survey results illustrated the personal nature of the issue for millions of Americans, with eight in 10 respondents saying they felt the cost of prescription medications has become "unreasonable" and one in five senior citizens saying they struggle to afford their prescriptions—including 17% who have prescription drug coverage as part of their insurance plans.
Democrats have long run on promises of lowering prescription drug costs, but with the provision within striking distance as part of the Build Back Better Act—the "human infrastructure" spending plan that would invest $3.5 trillion over a decade in the well-being of lower- and middle-income Americans—a small group of conservative party members have threatened to tank the package if the provision is included.
As Common Dreams reported last month, Reps. Kathleen Rice (D-N.Y.), Scott Peters (D-Calif.), and Kurt Schrader (D-Ore.) voted against including federal drug price negotiating power in the package. The latter two lawmakers have accepted tens of thousands of dollars from the pharmaceutical industry this election cycle.
Rice claimed last month that she would not support the provision because it was not "fiscally responsible" and would  "jeopardize the bill's final passage," while Schrader and Peters repeated an industry claim that allowing negotiations for lower drug prices would harm innovation in the pharmaceutical sector and prevent new drugs from being developed.
Respondents to the KFF survey rejected that claim; even after being presented with the argument, 82% of voters still supported allowing the government to negotiate prices. More than 70% of Republicans still supported the measure as well as 82% of independents.
"Even with [lobbying group] PhRMA spending millions on scare tactics and lies, voters know the truth," tweeted AARP, the national group that represents 38 million members over the age of 50.
Noting the wide swath of the electorate that backs the proposal, Sen. Bernie Sanders (I-Vt.)—who has played a key role in negotiating the Build Back Better Act as chairman of the Senate Budget Committee—called on lawmakers to "finally have the courage to stand up to the greed of Big Pharma."
In a call with reporters Tuesday, Sanders said that adding dental, hearing, and vision benefits to Medicare through the Build Back Better Act—also popular with the public—is similarly "not negotiable."
"The Democrats must stand with the people," added Sanders, "not fold."

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Manchin Fumes After Sanders Op-Ed in West Virginia Paper Calls Out Obstruction of Biden Agenda

"Poll after poll shows overwhelming support for this legislation," wrote Sanders. "Two Democratic senators remain in opposition, including Sen. Joe Manchin."

Andrea Germanos ·

US to Offer 'Condolence Payments' to Relatives of 10 Civilians Killed in Drone Strike

The Pentagon statement follows a call for President Joe Biden to "show real concern for civilians by taking more meaningful steps to prevent civilian casualties as a result of all U.S. lethal operations."

Andrea Germanos ·

New Filing Reveals Sinema Pads Campaign Coffers With More Pharma and Finance Funds

"This is what someone who's bought and paid for looks like."

Brett Wilkins ·

'We're Not Stopping': Weeklong D.C. Climate Protests End With 650+ Arrests, Vows to Fight On

"There is no other planet to escape to. Water is life... They need to listen to the youth. They need to hear us speak our cries."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.

Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo